Breast cancer‐derived K172N, D301V mutations abolish Na<sup>+</sup>/H<sup>+</sup> exchanger regulatory factor 1 inhibition of platelet‐derived growth factor receptor signalingShan Cheng, Junqi He, Longyan Yang et al.|FEBS Letters|2013Cited by 18
Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center StudyTongpeng Xu, Yue Zhou, Jian’an Bai et al.|Annals of Surgical Oncology|2024Cited by 8